PROKR2 Mutations in Patients with Short Stature Who Have Isolated Growth Hormone Deficiency and Multiple Pituitary Hormone Deficiency
Authors:
- Aslı Derya KardelenAKAslı Derya Kardelen
- Adam NajaflıANAdam Najaflı
- Firdevs BaşFBFirdevs Baş
- Birsen KaramanBKBirsen Karaman
- Güven ToksoyGTGüven Toksoy
- Şükran PoyrazoğluŞPŞükran Poyrazoğlu
- Şahin AvcıŞAŞahin Avcı
- Umut AltunoğluUAUmut Altunoğlu
- Zehra Yavaş AbalıZAZehra Yavaş Abalı
- Ayşe Pınar ÖztürkAÖAyşe Pınar Öztürk
- Esin Karakılıç-ÖzturanEKEsin Karakılıç-Özturan
- Seher BaşaranSBSeher Başaran
Open Access
- 21 November 2023
- journal article
- research article
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 15 (4) , 338-347
Abstract
Objective: Recent reports have indicated the role of the prokineticin receptor 2 gene (PROKR2) in the etiology of pituitary hormone deficiencies, suggesting a potential role for the PROK2 pathway in pituitary development, in addition to its role in gonadotropin releasing hormone-expressing neuron development. Here, we present the clinical and molecular findings of four patients with PROKR2 mutations.Methods: Next-generation targeted sequencing was used to screen 25 genes in 59 unrelated patients with multiple pituitary hormone deficiency (MPHD), isolated growth hormone (GH) deficiency, or idiopathic short stature.Results: Two different, very rare PROKR2 missense alterations classified as pathogenic (NM_144773.4:c.518T>G; NP_658986.1:p. (Leu173Arg)) and likely pathogenic (NM_144773.4:c.254G>A; NP_658986.1:p.(Arg85His)) were identified in four patients in heterozygous form. Patient 1 and Patient 2 presented with short stature and were diagnosed as GH deficiency. Patient 3 and Patient 4 presented with central hypothyroidism and cryptorchidism and were diagnosed as MPHD. No other pathogenic alterations were detected in the remaining 24 genes related to short stature, MPHD, and hypogonadotropic hypogonadism. Segregation analysis revealed asymptomatic or mildly affected carriers in the families.Conclusion: PROKR2 dominance should be kept in mind as a very rare cause of GH deficiency and MPHD. Expressional variation or lack of penetrance may imply oligogenic inheritance or other environmental modifiers in individuals who are heterozygous carriers.Keywords
This publication has 39 references indexed in Scilit:
- Variations inPROKR2, But NotPROK2, Are Associated With Hypopituitarism and Septo-optic DysplasiaThe Journal of Clinical Endocrinology & Metabolism, 2013
- PROK2/PROKR2 Signaling and Kallmann SyndromeFrontiers in Endocrinology, 2013
- Genetic Overlap in Kallmann Syndrome, Combined Pituitary Hormone Deficiency, and Septo-Optic DysplasiaThe Journal of Clinical Endocrinology & Metabolism, 2012
- A Genetic Basis for Functional Hypothalamic AmenorrheaNew England Journal of Medicine, 2011
- The Role of the Prokineticin 2 Pathway in Human Reproduction: Evidence from the Study of Human and Murine Gene MutationsEndocrine Reviews, 2010
- Oligogenic basis of isolated gonadotropin-releasing hormone deficiencyProceedings of the National Academy of Sciences, 2010
- PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activityHuman Molecular Genetics, 2008
- Mutations inProkineticin 2andProkineticin receptor 2genes in Human Gonadotrophin-Releasing Hormone Deficiency: Molecular Genetics and Clinical SpectrumThe Journal of Clinical Endocrinology & Metabolism, 2008
- Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadismProceedings of the National Academy of Sciences, 2007
- Kallmann Syndrome: Mutations in the Genes Encoding Prokineticin-2 and Prokineticin Receptor-2PLOS Genetics, 2006